Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Patients With Type 2 Diabetes

NCT00138554 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

318

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: vildagliptin
DRUG: pioglitazone

Sponsor

Novartis